, Volume 64, Issue 3, pp 245–249 | Cite as

Position 45 influences the peptide binding motif of HLA-B*44:08

  • Soumya Badrinath
  • Trevor Huyton
  • Heike Schumacher
  • Rainer Blasczyk
  • Christina Bade-DoedingEmail author
Brief Communication


Position 45 represents a highly polymorphic residue within HLA class I alleles, which contacts the p2 position of bound peptides in 85% of the peptide–HLA structures analyzed, while the neighboring residues 41 and 46 are not involved in peptide binding. To investigate the influence of residue 45 at the functional level, we sequenced peptides eluted from recombinant HLA-B*44:0841Ala/45Met/46Ala molecules and compared their features with known peptides from B*44:0241Thr/45Lys/46Glu. While HLA-B*44:02 has an anchor motif of E at the p2 anchor position, HLA-B*44:08 exhibits Q and L as anchor motif. The 45Met/Lys polymorphism contributes to the alteration in the peptide-binding motif and provides further evidence that mismatches at position 45 should be considered as nonpermissive in a transplantation setting.


Polymorphism Peptide-binding motif Stem cell transplantation 



The authors would like to thank Susanne Aufderbeck for the excellent technical assistance. This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01E00802).


  1. Bade-Doding C, Theodossis A, Gras S, Kjer-Nielsen L, Eiz-Vesper B, Seltsam A, Huyton T, Rossjohn J, McCluskey J, Blasczyk R (2011) The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family. Haematologica 96:110–8PubMedCrossRefGoogle Scholar
  2. Bade-Doeding, C., Cano, P., Huyton, T., Badrinath, S., Eiz-Vesper, B., Hiller, O., and Blasczyk, R.: Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P. Hum Immunol, 2011Google Scholar
  3. Bade-Doeding C, DeLuca DS, Seltsam A, Blasczyk R, Eiz-Vesper B (2007) Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants. Immunogenetics 59:253–9PubMedCrossRefGoogle Scholar
  4. Bade-Doeding C, Elsner HA, Eiz-Vesper B, Seltsam A, Holtkamp U, Blasczyk R (2004) A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands. Immunogenetics 56:83–8PubMedCrossRefGoogle Scholar
  5. Blume KG (1993) A general overview of the status of bone marrow transplantation for hematologic diseases. Leukemia 7:1078–9PubMedGoogle Scholar
  6. DeLuca DS, Khattab B, Blasczyk R (2007) A modular concept of HLA for comprehensive peptide binding prediction. Immunogenetics 59:25–35PubMedCrossRefGoogle Scholar
  7. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY (1990) Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 323:1818–22PubMedCrossRefGoogle Scholar
  8. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714–23PubMedCrossRefGoogle Scholar
  9. Hillen N, Mester G, Lemmel C, Weinzierl AO, Muller M, Wernet D, Hennenlotter J, Stenzl A, Rammensee HG, Stevanovic S (2008) Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype. Eur J Immunol 38:2993–3003PubMedCrossRefGoogle Scholar
  10. Hinrichs J, Foll D, Bade-Doding C, Huyton T, Blasczyk R, Eiz-Vesper B (2010) The nature of peptides presented by an HLA class I low expression allele. Haematologica 95:1373–80PubMedCrossRefGoogle Scholar
  11. Hirosawa M, Hoshida M, Ishikawa M, Toya T (1993) MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci 9:161–7PubMedGoogle Scholar
  12. Keever CA, Leong N, Cunningham I, Copelan EA, Avalos BR, Klein J, Kapoor N, Adams PW, Orosz CG, Tutschka PJ et al (1994) HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant 14:137–45PubMedGoogle Scholar
  13. Macdonald WA, Purcell AW, Mifsud NA, Ely LK, Williams DS, Chang L, Gorman JJ, Clements CS, Kjer-Nielsen L, Koelle DM, Burrows SR, Tait BD, Holdsworth R, Brooks AG, Lovrecz GO, Lu L, Rossjohn J, McCluskey J (2003) A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med 198:679–91PubMedCrossRefGoogle Scholar
  14. Petersdorf EW (2008) Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol 20:588–93PubMedCrossRefGoogle Scholar
  15. Prilliman KR, Jackson KW, Lindsey M, Wang J, Crawford D, Hildebrand WH (1999) HLA-B15 peptide ligands are preferentially anchored at their C termini. J Immunol 162:7277–84PubMedGoogle Scholar
  16. Sobocinski KA, Horowitz MM, Rowlings PA, Zhang MJ, Nugent ML, Passweg JR, Armitage JO, Gale RP, Bortin MM (1994) Bone marrow transplantation—1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. J Hematother 3:95–102PubMedCrossRefGoogle Scholar
  17. Theodossis A, Guillonneau C, Welland A, Ely LK, Clements CS, Williamson NA, Webb AI, Wilce JA, Mulder RJ, Dunstone MA, Doherty PC, McCluskey J, Purcell AW, Turner SJ, Rossjohn J (2010) Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc Natl Acad Sci USA 107:5534–9PubMedCrossRefGoogle Scholar
  18. Thomas ED (1985) High-dose therapy and bone marrow transplantation. Semin Oncol 12:15–20PubMedGoogle Scholar
  19. Thomas ED (1995) History, current results, and research in marrow transplantation. Perspect Biol Med 38:230–7PubMedGoogle Scholar
  20. Wahl A, Schafer F, Bardet W, Hildebrand WH (2010) HLA class I molecules reflect an altered host proteome after influenza virus infection. Hum Immunol 71:14–22PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Soumya Badrinath
    • 1
  • Trevor Huyton
    • 1
  • Heike Schumacher
    • 1
  • Rainer Blasczyk
    • 1
  • Christina Bade-Doeding
    • 1
    Email author
  1. 1.Institute for Transfusion MedicineHannover Medical SchoolHannoverGermany

Personalised recommendations